Indian Pharmaceuticals Company Taj Pharmaceuticals receives FDA approval for Generic Levothyroxine Sodium

12th November 2008, Indian Pharmaceuticals Company Taj Pharmaceuticals based in

Mumbai announced FDA approval for Levothyroxine Sodium Generic drug manufacturing

for regulatory market and non-regulated market.

The company is said to have approvals for different combinations of the drug, i.e. Thyroxine

sod. 50mcg, Thyroxine sod. 100mcg, Levothyroxine 80mcg, liothyronine 25mcg, Thyroxine

sod. 25mcg, Thyroxine sod. 37mcg, Thyroxine sod. 0.025mg, Thyroxine sod. 0.05mg,

Thyroxine sod. 0.1mg, Thyroxine sod. 12.5mcg, Thyroxine sod. 200mcg.

The generic manufacturing strategies of New Drug Levothyroxine Sodium and the product-

process of Taj Pharmaceuticals Ltd. are compared and collaborated using data from global

Pharmaceuticals manufacturing plants in the UK(Newcastle), US, Korea, Italy, Germany

and Japan.

The Indian company is eminent manufacturer, supplier and exporter of Levothyroxine

Sodium and various pharmaceuticals generics medicines in Tablets, capsules, Vial

(injections), ampule, Strips and schedule packs etc.

The companies integrated research team facilitates the affordable production of the drug for

even non-regulated markets of the world. i.e. Middle East, Thailand, Bangladesh etc.

The company is also involved in manufacturing of Active Ingredient of various

pharmaceuticals finished formulations in IP /BP / USP grades for all markets.

The approvals bring a positive uplift in the share market and public perception for

Pharmaceuticals investors.

Taj Pharmaceuticals LimitedWorking For Healthier World INDIA

FOR IMMEDIATE RELEASE

Mumbai - 12th November 2008 - Levothyroxine Sodium approval for Generic manufacturing given to Taj Pharmaceuticals from Food and Drug Administration India

Taj Pharma Group announces U S F D A t e n t a t i v e a p p r o v a l f o r V a r i o u s g e n e r i c M e d i c i n e s

Note: This site contains medical information that is intended for doctors or medical practitioner only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Privacy Policy and Terms of Use.© Copyright 2011 Taj Pharma Group (India),. All rights reserved.TAJ GROUP

PHARMACEUTICAL B U S I N E S S

Note: This site contains medical information that is intended for doctors or medical practitioner only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Privacy Policy and Terms of Use.© Copyright 2011 Taj Pharma Group (India),. All rights reserved.

TAJ GROUP

PHARMACEUTICAL B U S I N E S S

Taj Group of CompaniesTaj Pharmaceuticals Ltd.434, Laxmi Plaza, LaxmiIndustrial Estate, NewLink Road, Andheri (W),Mumbai- 400 053.India.

Phone : General EPA BX : 91 - (0)22 - 30601000 91 - (0)22 - 26374592 /92Fax : 91-(0)22-26341274

For Pharmaceuticals Company : http://www.tajpharma.com / http://www.tajpharmaceuticals.com

For Active Pharmaceuticals Ingredients : http://www.tajapi.com

For Drug & Doctors : http://www.tajdrug.com / http://www.tajfordoctors.com

Taj Pharmaceuticals LimitedWorking For Healthier World INDIA

About Taj Pharmaceutical Limited

Taj Pharmaceuticals Limited is a pharmaceutical company founded and based in India. The company manufacturers pharmaceutical formulations and API for India and other countries of world. The company was established in 1995 as an enterprise and in 2004 became a public limited company. As per Mumbai pharmaxil and Chemixil association the company manufacturers and exports to countries like Albania, Argentina, Austria, Chile and Iraq. In 1995 pharmaceuticals wing only has a schedule M certification for pharmaceuticals products manufacturing in India. Taj Pharmaceuticals established its manufacturing unit in Gujarat because of government policies in 1999 with WHO / GMP licence. The company in 2003 revived all the old manufacturing units and approached the FDA Gujarat for 4000 new pharmaceuticals drug permissions for the first time in India.

According to the Indian Trade Mark the company owns about 450 brands and 4600 generic manufacturing permissions in India. According to the export data analysis the company was the largest exporter of generic medicines to the Europe and Middle East countries.

The company medicines are present in France, Georgia, Egypt and CIF countries.

www.tajpharma.com

Media Contacts

Telephone +91-22-2637 4592 +91-22-2637 4593 +91-22-3060 1000Fax : +91-22-2634 1274For more Media details :media@tajpharma.com